Towards Healthcare Research & Consulting
Pet At-Home Diagnostic Tests Market
Updated Date: 10 July 2026   |   Report Code: 6643
[email protected] +1 804-441-9344
Download Sample Order Now

Pet At-Home Diagnostic Tests Market Growth, Innovations, and Market Size Forecast 2035

According to Shivani Zoting, who specializes in the diagnostics industry, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the pet at-home diagnostic test market The pet at-home diagnostic tests market was valued at USD 84.83 million in 2025 and reached USD 89.79 million in 2026, and it is projected to grow steadily to approximately USD 149.78 million by 2035, registering a CAGR of 5.85% from 2026 to 2035. Her analysis highlights the rising adoption of companion animals, increasing demand for convenient home-based diagnostic solutions, advancements in rapid testing technologies, growing awareness of preventive pet healthcare, and the expansion of tele-veterinary services. The research also examines the competitive strategies of key industry participants, including Zoetis Inc., IDEXX Laboratories, Inc., Virbac, Mars Incorporated, Heska Corporation, and Antech Diagnostics, shaping the future of the global pet diagnostics market.

Last Updated : 10 July 2026 Category: Diagnostics Insight Code: 6643 Format: PDF / PPT / Excel

Content

1. Executive Summary

  • 1.1. Market Overview
    • 1.1.1. Definition and Scope of the Pet At-Home Diagnostic Tests Market
    • 1.1.2. Market Size, Growth Rate, and Forecast (2025–2034)
  • 1.2. Key Strategic Insights
    • 1.2.1. Key Drivers and Trends in Pet At-Home Diagnostics
    • 1.2.2. Market Challenges and Barriers to Adoption
    • 1.2.3. Emerging Opportunities in Pet Healthcare

2. Market Overview and Industry Landscape

  • 2.1. Pet At-Home Diagnostics Technology Overview
    • 2.1.1. Advancements in Pet Diagnostic Test Technology
    • 2.1.2. Benefits of At-Home Diagnostics for Pet Owners
    • 2.1.3. Comparison of At-Home Diagnostic Tests vs. Veterinary Clinics
  • 2.2. Market Dynamics
    • 2.2.1. Market Drivers
    • 2.2.2. Market Restraints
    • 2.2.3. Opportunities in Pet Healthcare
    • 2.2.4. Consumer Adoption and Awareness Trends
  • 2.3. Value Chain Analysis
    • 2.3.1. Test Development and Manufacturing
    • 2.3.2. Distribution and Sales Channels
    • 2.3.3. Role of E-commerce in Market Expansion

3. Market Segmentation Analysis

  • 3.1. By Animal Type
    • 3.1.1. Dogs
      • 3.1.1.1. Market Size, Adoption, and Growth Trends
      • 3.1.1.2. Specific Testing Needs for Dogs (e.g., Parasitic, Infectious Diseases)
    • 3.1.2. Cats
      • 3.1.2.1. Market Dynamics and Consumer Preferences
      • 3.1.2.2. Unique Health Conditions in Cats and Diagnostic Solutions
    • 3.1.3. Others
      • 3.1.3.1. Market Growth and Adoption Trends in Other Pets
  • 3.2. By Application
    • 3.2.1. Parasitic Diseases
      • 3.2.1.1. Market Size, Growth Rate, and Key Drivers
      • 3.2.1.2. Popular Tests for Parasites in Pets
    • 3.2.2. Infectious Diseases
      • 3.2.2.1. Market Insights and Forecast
      • 3.2.2.2. Key Diagnostics for Infectious Diseases in Pets
    • 3.2.3. Fertility Testing
      • 3.2.3.1. Adoption of Fertility Tests and Market Trends
      • 3.2.3.2. Growth in Demand for At-Home Pet Fertility Solutions
    • 3.2.4. Chronic and Metabolic Diseases
      • 3.2.4.1. Market Trends and Forecast
      • 3.2.4.2. Importance of Chronic Disease Detection and Monitoring
    • 3.2.5. Genetic Conditions and Allergies
      • 3.2.5.1. Market Insights and Diagnostic Trends
      • 3.2.5.2. Genetic Screening and Allergy Testing for Pets
    • 3.2.6. Other
      • 3.2.6.1. Other Applications and Emerging Test Categories
  • 3.3. By Sample Type
    • 3.3.1. Blood
      • 3.3.1.1. Market Adoption and Test Accuracy
      • 3.3.1.2. Types of Blood Tests for Pets
    • 3.3.2. Urine
      • 3.3.2.1. Growth in Urine-Based Diagnostics
      • 3.3.2.2. Popular Urine Tests for Common Pet Diseases
    • 3.3.3. Fecal
      • 3.3.3.1. Demand for Fecal Diagnostics in Parasite Detection
      • 3.3.3.2. Market Size and Test Adoption Rates
    • 3.3.4. Others
      • 3.3.4.1. Emerging Test Sample Types
      • 3.3.4.2. Role of Non-traditional Sample Types in At-Home Diagnostics
  • 3.4. By Distribution Channel
    • 3.4.1. Veterinary Hospitals/Clinics
      • 3.4.1.1. Role of Clinics in Supporting At-Home Diagnostic Testing
      • 3.4.1.2. Adoption of At-Home Tests in Professional Settings
    • 3.4.2. E-commerce
      • 3.4.2.1. Growth of Online Pet Health Product Sales
      • 3.4.2.2. Market Share of E-commerce Platforms in Pet Diagnostics
    • 3.4.3. Retail Pharmacies
      • 3.4.3.1. Availability and Consumer Preferences in Retail Stores
      • 3.4.3.2. Market Trends in Retail Pharmacy Pet Diagnostics
  • 3.5. By Region
    • 3.5.1. North America
      • 3.5.1.1. Market Size & Trends (U.S., Canada, Mexico)
      • 3.5.1.2. E-commerce Adoption and Regulatory Trends
    • 3.5.2. South America
      • 3.5.2.1. Market Growth and Trends (Brazil, Argentina, Rest of South America)
    • 3.5.3. Europe
      • 3.5.3.1. Market Dynamics and Adoption Trends (Germany, UK, France, Spain, Italy)
      • 3.5.3.2. Regulatory Environment and Pet Health Regulations
    • 3.5.4. Asia Pacific
      • 3.5.4.1. Market Size and Growth Forecast (China, India, Japan, South Korea, ASEAN)
      • 3.5.4.2. Pet Healthcare Infrastructure and Adoption
    • 3.5.5. Middle East & Africa (MEA)
      • 3.5.5.1. Market Trends (South Africa, Saudi Arabia, UAE)
      • 3.5.5.2. Key Adoption Drivers in Emerging Markets

4. Cross-Segment Analysis

  • 4.1. Animal Type x Application x Sample Type
    • 4.1.1. Cross-Segment Adoption Trends by Pet Type and Application
    • 4.1.2. Test Sample Preferences and Diagnostic Application
  • 4.2. Distribution Channel x Region x Application
    • 4.2.1. Regional Distribution Insights for Different Pet Applications
    • 4.2.2. Market Access and Channel Adoption by Application Type
  • 4.3. Competitive Landscape across Segments
    • 4.3.1. Market Share and Positioning by Animal Type and Application
    • 4.3.2. E-commerce and Retail Pharmacy Penetration

5. Competitive Landscape

  • 5.1. Market Share Analysis
  • 5.2. Company Profiles
    • 5.2.1. Affordable Pet Labs
    • 5.2.2. Ring Biotechnology Co. Ltd.
    • 5.2.3. Forte Healthcare Ltd.
    • 5.2.4. Diagnostic Depot
    • 5.2.5. Wondfo USA Co., Ltd.
    • 5.2.6. Vitrosens Biotechnology
  • 5.3. Product Portfolio and R&D Focus
  • 5.4. Strategic Initiatives, Partnerships, and M&A Activity

6. Regulatory, Reimbursement, and Pricing Analysis

  • 6.1. Regulatory Environment for Pet Diagnostics
    • 6.1.1. Approval and Compliance Pathways for Pet Health Products
    • 6.1.2. Impact of Regulations on Pet Health Market Expansion
  • 6.2. Reimbursement Landscape
    • 6.2.1. Reimbursement Policies for At-Home Pet Diagnostic Tests
    • 6.2.2. Regional Differences in Insurance Coverage and Market Access
  • 6.3. Pricing Analysis
    • 6.3.1. Price Trends for Pet At-Home Diagnostic Tests
    • 6.3.2. Cost Analysis and Consumer Price Sensitivity

7. Market Forecast and Outlook

  • 7.1. Global Market Forecast (2025–2034)
    • 7.1.1. Market Size by Type, Application, and Region
    • 7.1.2. Growth Rate and Adoption Forecast by Segment
  • 7.2. Regional Market Forecast
    • 7.2.1. North America Forecast
    • 7.2.2. Europe Forecast
    • 7.2.3. Asia Pacific Forecast
    • 7.2.4. Latin America and MEA Forecast
  • 7.3. Scenario and Sensitivity Analysis
  • 8.1. Innovations in Pet Diagnostic Technologies
  • 8.2. Impact of E-commerce and Online Retail on Market Dynamics
  • 8.3. Key Risks, Barriers, and Mitigation Strategies
  • 8.4. Investment and Market Entry Opportunities

9. Conclusion

  • 9.1. Key Findings and Strategic Takeaways
  • 9.2. Long-Term Outlook for the Pet At-Home Diagnostic Tests Market

10. Appendix

  • 10.1. Glossary of Terms
  • 10.2. Research Methodology
  • 10.3. Assumptions and Limitations
  • 10.4. List of Tables and Figures

FAQ's

Answer : Pet at-home diagnostic tests market is predicted to increase from USD 89.79 million in 2026 to approximately USD 149.78 million by 2035, expanding at a CAGR of 5.85% from 2026 to 2035.

Answer : North America is currently leading the pet at-home diagnostic tests market due to high pet ownership, strong spending on pet healthcare.

Answer : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.  
Any Questions

Meet the Team

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar